Podcasts about Management

About this episode: In 1979, the town of Woburn, MA, raised the alarm as unusual numbers of children fell ill with leukemia. An investigation determined that this cancer cluster was likely caused by contaminated drinking water from two of the town's wells. In this episode: Suzanne Condon, who served as the associate commissioner of the Massachusetts Department of Health at the time, and Megan Latshaw, an expert in disease clusters, explain what the Woburn investigation highlights about unusual patterns of cancer and how they are studied. Guests: Suzanne Condon, MSM, is an environmental health expert who served as the associate commissioner of the Massachusetts Department of Health from 1980 to 2015. Megan Latshaw, PhD, MHS, is a professor in Environmental Health and Engineering at the Johns Hopkins Bloomberg School of Public Health. She is also the co-instructor of an online course on disease clusters. Host: Dr. Josh Sharfstein is distinguished professor of the practice in Health Policy and Management, a pediatrician, and former secretary of Maryland's Health Department. Show links and related content: How The Post found growing rates of cancer in America's Corn Belt—Washington Post Disease Clusters—Coursera LEUKEMIA STRIKES A SMALL TOWN—New York Times Childhood Leukemia in Woburn, Massachusetts—Public Health Reports Transcript information: Looking for episode transcripts? Open our podcast on the Apple Podcasts app (desktop or mobile) or the Spotify mobile app to access an auto-generated transcript of any episode. Closed captioning is also available for every episode on our YouTube channel. Contact us: Have a question about something you heard? Looking for a transcript? Want to suggest a topic or guest? Contact us via email or visit our website. Follow us: @‌PublicHealthPod on Bluesky @‌JohnsHopkinsSPH on Instagram @‌JohnsHopkinsSPH on Facebook @‌PublicHealthOnCall on YouTube Here's our RSS feed Note: These podcasts are a conversation between the participants, and do not represent the position of Johns Hopkins University.

What does leadership look like when the world keeps shifting beneath you? Dara Treseder—Chief Marketing Officer of Autodesk—joins Guy to share how people-first decision-making and focusing on what you can control help leaders stay grounded in uncertain times.Dara breaks down how Autodesk's design-and-make platform touches everything from buildings to Oscar-winning films, and why bold moves like partnering with the LA28 Olympics require clarity, conviction, and resilience. She also speaks candidly about navigating bias, imposter syndrome, and the pressure of being “the only” in many rooms.This conversation is a powerful reminder that courage isn't loud—it's consistent, intentional, and rooted in how you show up for others and for yourself.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Text Dr. Lenz any feedback or questions In this episode of the Conquering Your Fibromyalgia podcast, host Mike introduces the podcast's first medical doctor guest, Dr. Maureen Allen. Dr. Allen shares her extensive journey from being a nurse to becoming a family medicine physician and an emergency medicine expert in Nova Scotia, Canada. The episode dives deep into the complexities of managing chronic pain, explaining how palliative care intersects with chronic pain treatment and the challenges patients face in finding the right care. They discuss the distinctions between acute and chronic pain, the role of emergency departments, and the need for a bottom-up approach to pain management. Dr. Allen also highlights the importance of patient education and shares insights from her own practice to help listeners understand and manage chronic pain more effectively.Watch on YouTube HERE00:00 Welcome to the Conquering Your Fibromyalgia Podcast00:10 Introducing Dr. Maureen Allen00:55 Dr. Allen's Medical Journey01:54 Chronic Pain and Palliative Care02:36 Addressing Misconceptions About Substance Use04:00 Challenges in Diagnosing Fibromyalgia05:39 Pain Education and Management in Canada09:08 Emergency Departments and Pain Management13:09 Understanding Chronic Pain Flare-ups20:13 Patient Concerns and Misdiagnoses23:29 Understanding Chronic Pain24:22 Acute Pain vs. Chronic Pain25:30 Pain Protective Behaviors27:33 The Role of Exercise in Pain Management32:27 The Intersection of Anxiety and Pain36:05 The Importance of Education and Support40:29 Real Stories and Hope Click here for the YouTube channel International Conference on ADHD in November 2025 where Dr. Lenz will be one of the speakers. Support the showWhen I started this podcast and YouTube Channel—and the book that came before it—I had my patients in mind. Office visits are short, but understanding complex, often misunderstood conditions like fibromyalgia takes time. That's why I created this space: to offer education, validation, and hope. If you've been told fibromyalgia “isn't real” or that it's “all in your head,” know this—I see you. I believe you. This podcast aims to affirm your experience and explain the science behind it. Whether you live with fibromyalgia, care for someone who does, or are a healthcare professional looking to better support patients, you'll find trusted, evidence-based insights here, drawn from my 29+ years as an MD. Please remember to talk with your doctor about your symptoms and care. This content doesn't replace per...

EY's Global Consulting AI Leader Dan Diasio joins host Molly Wood to discuss the future of work and how companies can reinvent themselves as AI-first Frontier Firms. Learn how AI is disrupting the consulting industry, why investing in upskilling your employees is now mandatory, and why the right combination of mindset, skill set, and tool set matters more than ever. Listen in to discover practical strategies for leaders to drive transformation and compete with AI-native disruptors. WorkLab | Subscribe to the WorkLab Newsletter

EY's Global Consulting AI Leader Dan Diasio joins host Molly Wood to discuss the future of work and how companies can reinvent themselves as AI-first Frontier Firms. Learn how AI is disrupting the consulting industry, why investing in upskilling your employees is now mandatory, and why the right combination of mindset, skill set, and tool set matters more than ever. Listen in to discover practical strategies for leaders to drive transformation and compete with AI-native disruptors. WorkLab | Subscribe to the WorkLab Newsletter

What if the biggest barrier to your leadership success isn't your skills, but your beliefs? In this episode, Kevin sits down with Muriel Wilkins to discuss how deeply held beliefs can limit our growth and impact as leaders. Muriel shares how many high-performing leaders unconsciously operate from outdated or misaligned beliefs; beliefs that may have once served them but now hinder their effectiveness. They also talk about how these "blocking beliefs" develop, why they are so hard to recognize, and how to reframe them to align with who we are becoming as leaders. Muriel's Story: Muriel M. Wilkins is the author of Leadership Unblocked: Break Through the Beliefs That Limit Your Potential and coauthor of Own the Room: Discover Your Signature Voice to Master Your Leadership Presence. She is the founder and CEO of Paravis Partners, a sought-after C-suite adviser and executive coach with a twenty-year track record of helping senior leaders take their performance to the next level. Muriel is also the host of the Harvard Business Review Podcast, Coaching Real Leaders, consistently ranked as a top-ten podcast in Apple's Management category. https://www.murielwilkins.com/ https://www.linkedin.com/in/murielwilkins/ https://www.instagram.com/coachmurielwilkins This Episode is brought to you by... Flexible Leadership is every leader's guide to greater success in a world of increasing complexity and chaos.  Book Recommendations Leadership Unblocked: Break Through the Beliefs That Limit Your Potential by Muriel M. Wilkins  Sovereign Love: A Guide to Healing Relationships by Reclaiming the Masculine and Feminine Within by Dené Logan  Codependent No More: How to Stop Controlling Others and Start Caring for Yourself by Melody Beattie  Like this? Understanding the Success Mindsets with Ryan Gottfredson The Mindsets That Separate the Best Leaders with Vikram Malhotra Five Mindsets to Lead Well with Paula Davis Podcast Better! Sign up with Libsyn and get up to 2 months free! Use promo code: RLP   Join Our Community If you want to view our live podcast episodes, hear about new releases, or chat with others who enjoy this podcast join one of our communities below. Join the Facebook Group Join the LinkedIn Group   Leave a Review If you liked this conversation, we'd be thrilled if you'd let others know by leaving a review on Apple Podcasts. Here's a quick guide for posting a review. Review on Apple: https://remarkablepodcast.com/itunes   

Can ChatGPT dethrone Gemini? Is Tim Cook capable of leading Apple into the next wave of AI? As 2025 winds down, journalist and podcast host Kara Swisher joins Rapid Response to cut through the noise and decode what's really happening across OpenAI, Meta, Google, and more. Swisher also sizes up the state of Disney, Netflix, and the escalating bidding war for Warner Bros. Discovery. And in classic Swisher fashion, she doesn't hold back — weighing in on Elon Musk's eye-popping potential pay package, Mark Zuckerberg's costly misfires at Meta, and what the future of AI means for human health and cognition.Visit the Rapid Response website here: https://www.rapidresponseshow.com/See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Welcome back to TBB aka The Bestie Bonus Episode 63, where we will be going down a spiral with Taylar! This week we discuss encounters with loved ones at the time of their passing or after in our Question of the Week before diving into Shared Death Experiences! Thanks so much for joining us! Can't wait to catch up with you on Thursday! Talk to ya then, love ya!! Thank you to everyone who has submitted their story, if you would like to submit one you can do so through our Reddit @CreepsandCrimes or our email creepsandcrimes.ca@gmail.com with the title being Spiritual Encounter or Creepy Account! Need to Call Susan (Angel Wings and Healing Things)? Text Ellen at 704-562-3476 to book!! Make sure to tell her we sent you for a Besties only Special discount!! If you have a Creepy Account of your own you would like to submit, you can go to our Reddit (CreepsandCrimes) or email it to us at CREEPSANDCRIMES.CA@GMAIL.COM Creeps and Crimes Merch: ⁠⁠https://creepsandcrimesmerch.com/⁠⁠ Join our OG Pick Me Cult (Patreon): ⁠⁠https://patreon.com/creepsandcrimes⁠⁠ SUBSCRIBE AND SUPPORT WHEREVER YOU GET YOUR PODCASTS: - Apple Podcast: ⁠⁠https://podcasts.apple.com/us/podcast/creeps-and-crimes/id1533194848⁠⁠ - Spotify: ⁠⁠https://open.spotify.com/show/0v2kntCCfdQOSeMNnGM2b6?si=bf5c137913dd4af7⁠⁠ - Youtube: ⁠⁠https://youtube.com/@creepsandcrimespodcast?si=e6Lwuw6qvsEPBHzG⁠⁠ Business Inquiries please contact Management: ⁠⁠maggie@MRHentertainment.com⁠⁠ FOLLOW US ON SOCIALS: Creeps and Crimes Podcast - Insta: ⁠⁠https://www.instagram.com/creepsandcrimespodcast/?hl=en⁠⁠ - Facebook: ⁠⁠https://www.facebook.com/creepsandcrimespodcast/⁠⁠ - TikTok: ⁠⁠https://www.tiktok.com/@creepsandcrimes⁠⁠ Taylar Jane (True Crime Host) - Insta: @Taylarj - TikTok (True Crime Channel): @TaylarJane98 - TikTok (Personal): @TaylarJane1 Morgan Harris (Paranormal & Conspiracy Host) - Insta: @morgg.m - Tiktok: @morgg.m Want More Info? Check out our Website: ⁠⁠www.creepsandcrimespodcast.com⁠⁠ Send Us Mail & Fan Art to our PO Box!!! CREEPS AND CRIMES PODCAST PO BOX 11523 KNOXVILLE, TENNESSEE 37939 Have a Creepy Account You'd like to share and be featured on the Podcast? Email it to: ⁠⁠CreepsAndCrimes.CA@gmail.com⁠⁠ Submit it through the Portal on our Website (Listed above) or Post in on our Reddit Thread with the tag "creepy account" Love our TBB episodes and want to get in on the Action or submit an AIMS? Head over to our Reddit Community: @creepsandcrimes Need to contact us or request sources? Email us at ⁠⁠creepsandcrimespodcast@gmail.com Learn more about your ad choices. Visit podcastchoices.com/adchoices

Dr. Natalie Crawford, a board-certified OBGYN and REI, guides listeners through the often misunderstood world of pregnancy loss. Using both her professional knowledge and personal insights, she helps you gain confidence in understanding this experience, whether you're facing it yourself or supporting someone who is. Find out what's actually happening, why it matters, and the important steps you can take next. Key Topics: 1. What Is Pregnancy Loss? - Common types of pregnancy loss and what the medical terms mean - Why pregnancy loss happens more frequently than most people realize - Dispelling shame and myths 2. Navigating the Emotional Experience - The wide range of feelings and reactions people may have. - Encouraging openness and seeking support from loved ones. - Why it's okay to grieve in your own way and at your own pace. 3. Understanding the Causes - Overview of possible reasons, from genetics to physical health - How hormones and biology can impact pregnancy. - Emphasizing that many factors are beyond one's control 4. Management & Healing - What to expect medically: natural healing, medication options, and procedures. - The importance of follow-up care and monitoring. - Pathways to recovery and when to consider further evaluation. Pre-order Dr. Crawford's debut book, The Fertility Formula, now! ⁠https://www.nataliecrawfordmd.com/book⁠ Want to receive my weekly newsletter? Sign up at ⁠⁠⁠⁠nataliecrawfordmd.com/newsletter⁠⁠⁠⁠ to receive updates, Q&A, special content, and freebies If you haven't already, please rate, review, and follow the podcast to be notified of new episodes every Tuesday. Plus, be sure to follow along on Instagram ⁠⁠⁠⁠@nataliecrawfordmd,⁠⁠⁠⁠ check out Natalie's YouTube channel Natalie Crawford MD⁠⁠⁠⁠, and if you're interested in becoming a patient, check out ⁠⁠⁠⁠Fora Fertility. Join the Learn at Pinnacle app ⁠to earn FREE CE Credit for listening to this episode! This episode is brought to you by The Pinnacle Podcast Network! Learn more about Pinnacle at http://learnatpinnacle.com Learn more about your ad choices. Visit megaphone.fm/adchoices

How mindset, hunger management, and practical tools can make fasting easier and more sustainable. Episode #235

The most powerful leadership tool you have isn't authority or expertise, but attention. In this episode, I sit down with Dr. Ravi Kudesia, Associate Professor of Management at Temple University's Fox School of Business, to break down the science and practice of mindful leadership. We talk about how leaders can regulate their attention, reset your energy between meetings, disrupt habitual scripts, and guide teams through ambiguity without creating panic. Ravi shares how mindfulness helps leaders read the room, experiment more effectively during change, and model emotional grounding for their teams. Get ready to rethink how you show up and discover why mindful leaders make change feel less like chaos and more like possibility. Check out our sponsors: Northwest Registered Agent - Protect your privacy, build your brand and get your complete business identity in just 10 clicks and 10 minutes! Visit https://www.northwestregisteredagent.com/achieverfree In this Episode, You Will Learn 00:00 How do you prepare to teach, lead, and be present? 07:00 How to reset between meetings and clear “attentional residue.” 09:45 A breathing reset you can use anywhere to calm your system. 14:30 Why leaders must shift from individualistic to relational leadership mindsets. 21:15 How a leader's internal state shapes the emotional health of the entire team. 27:15 How do you lead through change? 33:00 Why middle leaders must become adapters and experiment in ambiguity. 39:45 How leaders can ask better questions in the middle of uncertainty.  43:00 How attuning to energy in the room changes the way leaders lead. 46:30 What leaders do to cultivate mindfulness? Resources + Links Get a copy of my book - The Anxious Achiever Watch the podcast on YouTube  Find more resources on our website morraam.com Follow Follow me: on LinkedIn @morraaronsmele + Instagram @morraam Follow Ravi on LinkedIn: @rskudesia

Andy and Eric discuss the challenges faced in the plumbing and construction industry, particularly focusing on management issues, team dynamics, quality control, and the importance of documentation. They address a listener's concerns about managing a team with varying skill levels and the pressure to meet deadlines. The discussion emphasizes the need for skilled labor, effective training, and accountability in the workplace, as well as the significance of thorough testing and quality assurance in plumbing work.Send us a textSend us your feedback or topic ideas over on our social channels!Eric Aune @mechanicalhub Andy Mickelson @mick_plumbNewsletter sign up: https://bit.ly/MH_email

In this episode, I'm joined by Hayley Mears, former hairdresser, branding expert, and the driving force behind Six Underground Media. Hayley is also one of the guest educators inside our marketing course, and she brings a level of insight into social media, branding, and digital trends that most salon owners simply don't have access to.We dive deep into what salon owners should expect from Instagram in 2026, why the platform is about to shift in a major way, and how AI is going to become a natural part of your marketing workflow, whether you like it or not. Hayley also opens up about outsourcing, building teams globally, why email addresses are more valuable than followers, and how Canva has democratised design for salon owners everywhere.If you want to stay ahead of the curve, understand what's changing, and get practical, real-world advice from someone who lives and breathes digital marketing for salons, you're going to love this conversation.IN THIS EPISODE:[02:23] Instagram trends coming in 2026[04:26] Auto-responses, ManyChat, and in-app automations[06:00] The overwhelm salon owners feel around tech and social media[07:26] Should salons outsource or DIY their social?[08:59] Why capability and confidence aren't the same thing[09:39] The shift in what salons need from social agencies[17:41] Three things to focus on for Instagram in 2026[18:21] Why storytelling matters more than ever[21:04] How to use AI for content and campaign ideas[27:27] Canva: why every salon should be using itWant MORE to help you GROW?

Jason Bronstad is the CEO of Malk Organics, a clean-label, plant-based milk and creamer brand. Jason began his career in the food and beverage industry at Sara Lee, serving across several managerial and directorial positions between 2004 and 2010. He then went on to become VP of Sales at Mike's Hard Lemonade and then the President of Mighty Swell Cocktail Company before joining purpose-led start up, Malk Organics, in 2020. He joins Roy to discuss the ins and outs of shaping culture, values-driven hiring, evaluating talent, learning to keep things simple, and much more. Highlights from our conversation include:Core beliefs and values that comprise Jason's leadership playbook (3:55)Connection to mission (6:12)Hiring lessons learned during periods of brand growth and development (8:20)Key characteristics of high-performing leaders (11:40)Important traits Jason seeks in his direct reports (14:15)Evaluating cultural fit in prospective talent (15:50)The parts of Malk's culture that make Jason most proud (18:08)Jason's definition of success and how it's evolved over the course of his career (20:22)His advice for the next generation of CPG leaders (21:10)

A yawn spreads quickly. You see someone yawn, you think about yawning, or you even read the word “yawn”—and suddenly you're doing it too. This episode begins by looking at why yawning is so contagious, what theories actually hold up, and what science still can't explain. https://www.livescience.com/human-behavior/why-is-yawning-contagious A Christmas tree seems like such a natural part of the holiday season, but the tradition behind it is rich, surprising, and deeply woven into American history. Why an evergreen? Where did the practice originate? How do they select the giant tree for Rockefeller Center every year? Here to explain the story and the symbolism behind the Christmas tree is Trent Preszler, professor of Applied Economics and Management at Cornell University and author of the book Evergreen: The Trees That Shaped America. (https://amzn.to/43NUVSj). Dining out today is nothing like it was just a few years ago. Prices are higher, tipping culture has shifted, customer expectations are changing, and restaurants face tighter margins than ever. Adam Reiner joins me with a behind-the-scenes look at what's really happening in the industry and offers practical advice for getting the best experience when you eat out. Adam is a food writer whose work has appeared in Bon Appétit, Food & Wine, and New York Magazine, and he's author of The New Rules of Dining Out (https://amzn.to/3Xhg0kf). You would think eating food should satisfy you—yet some foods do the opposite. Highly processed foods digest so quickly and trigger such different responses in your body that they can actually leave you hungrier. I explain what the science shows and why these foods can lead to overeating. https://www.nih.gov/news-events/nih-research-matters/eating-highly-processed-foods-linked-weight-gain PLEASE SUPPORT OUR SPONSORS! AURA FRAMES: Visit ⁠⁠⁠https://AuraFrames.com⁠⁠⁠ and get $45 off Aura's best selling Carver Mat frames by using promo code SOMETHING at checkout. INDEED: Get a $75 sponsored job credit to get your jobs more visibility at ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://Indeed.com/SOMETHING⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ right now! DAVID GREENE IS OBSESSED: We love the "David Greene Is Obsessed" podcast! Listen at ⁠ https://link.mgln.ai/SYSK⁠ or wherever you get your podcasts. QUINCE: Give and get timeless holiday staples that last this season with Quince.  Go to ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://Quince.com/sysk⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ for free shipping on your order and 365 day returns! DELL: It's time for Cyber Monday at Dell Technologies. Save big on PCs like the Dell 16 Plus featuring Intel® Core™ Ultra processors. Shop now at: ⁠⁠⁠⁠⁠⁠ https://Dell.com/deals ⁠⁠⁠⁠⁠⁠ AG1: Head to ⁠⁠⁠⁠⁠⁠https://DrinkAG1.com/SYSK ⁠⁠⁠⁠⁠⁠ to get a FREE Welcome Kit with an AG1 Flavor Sampler and a bottle of Vitamin D3 plus K2, when you first subscribe!  NOTION: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Notion brings all your notes, docs, and projects into one connected space that just works . It's seamless, flexible, powerful, and actually fun to use! Try Notion, now with Notion Agent, at: ⁠⁠⁠⁠⁠⁠https://notion.com/something⁠⁠⁠⁠⁠⁠ PLANET VISIONARIES: In partnership with Rolex's Perpetual Planet Initiative, this… is Planet Visionaries. Listen or watch on Apple, Spotify, YouTube, or wherever you get your podcasts. Learn more about your ad choices. Visit megaphone.fm/adchoices

What if the biggest threat to your brand's profitability isn't the next tariff or supply chain disruption, but an outdated playbook that forces you to choose between raising prices on loyal customers or sacrificing your margins?Agility requires more than just reacting quickly to market changes; it requires the intelligence to anticipate them and automate the optimal response. Today, we're going to talk about how leading retail brands are navigating complex economic pressures like tariffs and inflation—not by resorting to the old tactics of deep discounts or across-the-board price hikes, but by deploying AI to create a more resilient and intelligent operation. We'll explore how AI is helping brands maintain pricing stability, turn insights from major shopping events into real-time strategy, and fundamentally shift teams from staring at dashboards to taking automated, margin-protecting actions. To help me discuss this topic, I'd like to welcome, Sai Koppala, CMO at CommerceIQ. About Sai Koppala Sai brings over 20 years of marketing and strategy experience. Before CommerceIQ, he was Chief Marketing & Strategy Officer at SheerID and held leadership roles at Apigee (acquired by Google) and SAP. He holds an MBA from the Kellogg School of Management and a Master's in Electrical Engineering from Arizona State University. Sai Koppala on LinkedIn: https://www.linkedin.com/in/koppala/ Resources CommerceIQ: https://www.commerceiq.com The Agile Brand podcast is brought to you by TEKsystems. Learn more here: https://www.teksystems.com/versionnextnow Catch the future of e-commerce at eTail Palm Springs, Feb 23-26 in Palm Springs, CA. Go here for more details: https://etailwest.wbresearch.com/ Connect with Greg on LinkedIn: https://www.linkedin.com/in/gregkihlstromDon't miss a thing: get the latest episodes, sign up for our newsletter and more: https://www.theagilebrand.showCheck out The Agile Brand Guide website with articles, insights, and Martechipedia, the wiki for marketing technology: https://www.agilebrandguide.com The Agile Brand is produced by Missing Link—a Latina-owned strategy-driven, creatively fueled production co-op. From ideation to creation, they craft human connections through intelligent, engaging and informative content. https://www.missinglink.company

BONUS: Impact Engineering—Finding Agile's Lost North Star With Tom Gilb and Simon Holzapfel The Clarity Problem: Why Organizations Start with "Fuzzy B*S*!" "Everybody seems to start from a position of fuzzy b*s*. Nice-sounding words. Management does it, professors do it, politicians do it. And they don't even feel very guilty about it."   Tom Gilb doesn't mince words when describing how most organizations define their objectives. The fundamental problem isn't a lack of ambition—it's a lack of clarity. When leaders are asked about their critical values like "extremely high security" or "employee happiness," they typically respond with circular definitions that provide no actionable direction. Tom's approach starts by exposing this gap and then demonstrating that any value—no matter how "soft" or intangible it seems—can be quantified. Using AI tools, he's shown clients over 1,400 different ways to measure human happiness alone. Why Agile Lost Its North Star "Agile's lost its North Star because the economic problems it was trying to solve within the organization are now mismatched with the digital world."   Simon Holzapfel offers a structural analysis: Agile developed primarily to allay the concerns of pre-digital capital—investors who needed reassurance that their money wouldn't disappear into failed projects. But today's digital economy operates differently. Capital now moves like a service (SaaS model), and innovation is fundamentally stochastic—you can't predict when breakthroughs will happen. Organizations using flow-focused tools when the real problem is value creation are applying yesterday's solutions to today's challenges. The First Step: Quantify Your Critical Values "If you ask AI to quantify employee happiness a hundred different ways, it will do it in one minute for free. So you can no longer be in denial."   The path forward starts with brutal honesty about what your organization actually cares about. Tom's approach involves:   Identifying the top 10 critical stakeholder values Defining clear scales of measure for each Establishing where you are now (status) Setting where you need to be to survive (tolerable level) Defining what success looks like (target/goal level)   This isn't about adding bureaucracy—it's about creating shared clarity that enables everyone to row in the same direction.   About Tom Gilb and Simon Holzapfel   Tom Gilb, born in the US, lived in London, and then moved to Norway in 1958. An independent teacher, consultant, and writer, he has worked in software engineering, corporate top management, and large-scale systems engineering. As the saying goes, Tom was writing about Agile before Agile was named. In 1976, Tom introduced the term "evolutionary" in his book Software Metrics, advocating for development in small, measurable steps. Today, we talk about Evo, the name Tom uses to describe his approach. Tom has worked with Dr. Deming and holds a certificate personally signed by him. You can listen to Tom Gilb's previous episodes here.    You can link with Tom Gilb on LinkedIn    Simon Holzapfel is an educator, coach, and learning innovator who helps teams work with greater clarity, speed, and purpose. He specializes in separating strategy from tactics, enabling short-cycle decision-making and higher-value workflows. Simon has spent his career coaching individuals and teams to achieve performance with deeper meaning and joy. Simon is also the author of the Equonomist newsletter on Substack. And you can listen to Simon's previous episodes on the podcast here.    You can link with Simon Holzapfel on LinkedIn.

For much of the last century, a steady career often meant staying with one company for decades. But that idea started to fade in the ‘80s and ‘90s as layoffs and restructuring made long-term loyalty feel less secure. By the 2000s, job hopping became the norm and often led to better pay and benefits.But today, something new is happening. Alongside job hopping, we're seeing a rise in job hugging — people staying put, even when they'd rather move, because the job market feels uncertain. MPR News guest host Chris Farrell talks about shifting hiring trends, when it's smart to switch jobs, when it's best to stay and what it all means for our careers and workplaces.Guests:Alan Benson is an associate professor at the University of Minnesota's Carlson School of Management where he researches hiring, promotions and employment.Mark Sorenson-Wagner is the director of career development at the University of St. Thomas.

L'édition 2026 du Festival international de la bande dessinée (FIBD) d'Angoulême, prévue du 29 janvier au 1er février 2026, vient d'être « mise à l'arrêt » par 9ᵉ Art+ la société privée qui l'organise. De nombreux acteurs du secteur avaient décidé de boycotter ce grand rendez-vous de la BD.Visée par de nombreuses critiques depuis dix ans, la société organisatrice du FIBD a récemment été accusée d'avoir licencié une employée assurant avoir été victime de viol lors de l'édition 2024. Management violent, gestion commerciale, apologie de l'inceste et de la pédocriminalité… Le naufrage du rendez-vous de la BD était malheureusement annoncé. Récit, dans cet épisode de Code Source, avec Emeline Collet, journaliste au service culture du Parisien.Écoutez Code source sur toutes les plates-formes audio : Apple Podcast (iPhone, iPad), Amazon Music, Podcast Addict ou Castbox, Deezer, Spotify.Crédits. Direction de la rédaction : Pierre Chausse - Rédacteur en chef : Jules Lavie - Reporter : Barbara Gouy - Production : Clara Garnier-Amouroux, Anaïs Godard et Clémentine Spiler - Réalisation et mixage : Julien Montcouquiol - Musiques : François Clos, Audio Network - Archives : TikTok/eliseasmr. Hébergé par Acast. Visitez acast.com/privacy pour plus d'informations.

 It is that time of year – you have a list of things to do that is nearly a mile long. Your mind is scrambled, and you are trying to remember what you need to do for the practice and team to wrap up 2025 nicely. Dr. Kuba and Bethany are here to help! Together, they put together a list of their top year-end tips and reminders. Some of the items are easy to forget, like evaluating your fee schedule, while others are more challenging like evaluating your A/R trends. Nonetheless, this episode will help you maximize the last few weeks of this year to ensure that everything is checked off your list (and hopefully you don't have to check it twice!).  If you're a subscriber, don't miss the BLACK FRIDAY SALE on the Hub. For the next 3 days, all Hub resources are 50% off!! 

Send us a text

Spine specialist, Dr. Nate McKee shares a success story about a patient with tandem stenosis. Dr. Nate McKee grew up in Fort Wayne, IN. He was first introduced to the great state of Michigan, when he attended Albion College. At Albion College, Dr. Nate received his Bachelor's in Exercise Sciences. He then went onto National University of Health Sciences in Lombard, IL where he received his Doctorate in Chiropractic. While at National, he was actively involved in the Student American Chiropractic Association, and was President. During that involvement he lobbied in Washington, D.C. for rights and access for chiropractic patients such as: Veteran's access, underserved areas, Tricare, etc. Dr. Nate was also a school tutor for Head & Neck and Thoracic Evaluation, Management, and Manipulation courses for two years. During his clinical experience, Dr. Nate did a 2 month rotation at the Roudebush VA Medical Center in Indianapolis, IN.  Dr. Nate has furthered his education and received a certification in Cox Decompression and Manipulation Technic. His education in Cox Technic allows him to treat various conditions of the neck, back, and knees such as but not limited to: disc herniations, spinal stenosis, post surgical pain, back pain related to pregnancy, headaches, and meniscal pain of the knee.  Dr. Nate is also a Certified Chiropractic Sports Physician® (CCSP®), which has equipped him with the training to treat and prevent sports injuries and to properly work with athletes.  References: Chiropractic Management using Cox Technic Flexion Distraction for a Patient With Tandem Spinal Stenosis Resources: Connect with Dr. McKee Dr. Mckee's office 810-223-2439 Connect on Facebook Instagram @McKeeChiro Find a Back Doctor The Cox 8 Table by Haven Medical

Review for Final Exam Business Finance, FIL 240-002, Autumn 2025, Lecture 29 Type: mp3 audio file ©2025

Review for Final Exam Business Finance, FIL 240-001, Autumn 2025, Lecture 29 Type: mp3 audio file ©2025

Dr. Shad Morris is a Professor of Management at the Marriott School of Business and the Director of the Whitmore Global Business Center. In this discussion, Dr. Morris shares inspiring stories about international experiences in education and business that will change the way you think about stepping out of your comfort zone and taking global opportunities. 

In this inspiring episode of our Alumni Spotlight series, we sit down with Vanessa Ramirez, a proud graduate of the Law Magnet Class of 2013.With over 12 years of experience in project management, Vanessa has led major initiatives for global industry giants like Verizon, PDI Technologies, and Goldman Sachs. Holding dual master's degrees in Business Administration (MBA) and Public Administration (MPA), she is known for her leadership, innovation, and dedication to helping teams succeed.In this conversation, we discuss:From Townview to Tech: How her Law Magnet foundation shaped her professional journey.Corporate Leadership: Lessons learned managing initiatives for companies like Goldman Sachs.Finding Purpose: Advice on career growth, perseverance, and making an impact through technology.Join us as we celebrate 50 years of the School of Business and Management and 30 years of Townview Magnet Center excellence.Keywords: Project Management, Women in STEM, Townview, Law Magnet, Career Advice, MBA, MPA, Goldman Sachs.

In this inspiring episode of our Alumni Spotlight series, we sit down with Vanessa Ramirez, a proud graduate of the Law Magnet Class of 2013.With over 12 years of experience in project management, Vanessa has led major initiatives for global industry giants like Verizon, PDI Technologies, and Goldman Sachs. Holding dual master's degrees in Business Administration (MBA) and Public Administration (MPA), she is known for her leadership, innovation, and dedication to helping teams succeed.In this conversation, we discuss:From Townview to Tech: How her Law Magnet foundation shaped her professional journey.Corporate Leadership: Lessons learned managing initiatives for companies like Goldman Sachs.Finding Purpose: Advice on career growth, perseverance, and making an impact through technology.Join us as we celebrate 50 years of the School of Business and Management and 30 years of Townview Magnet Center excellence.Keywords: Project Management, Women in STEM, Townview, Law Magnet, Career Advice, MBA, MPA, Goldman Sachs.

How does a country sliding toward autocracy affect its economy? Political scientist and author Barbara F Walter offers data-driven insights about why the murky middle ground between democracy and autocracy is bad for business. She talked with host Jeff Berman live on stage at the 2025 Masters of Scale Summit. Walter's book: https://bookshop.org/p/books/how-civil-wars-start-and-how-to-stop-them-barbara-f-walter/35f702a0af16f18aWalter's Substack: https://barbarafwalter.substack.com/Subscribe to the Masters of Scale weekly newsletter: https://mastersofscale.com/newsletter/See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Play audio-only episode | Play video episode | Play on YouTube | Play on Spotify Click above to play either the audio-only episode or video episode in a new window. Episode Summary Subtle problems often start long before a project shows obvious signs of distress. Leaders feel the pressure to deliver momentum, teams shift toward activity over outcomes, and stakeholders slowly fade as competing priorities pull them away. In this conversation, Matthew Oleniuk brings his experience from overseeing large public sector projects and highlights seven early indicators that signal when a project is heading toward trouble. He explains why these issues are easy to ignore, how they quietly compound over time, and why strong leadership vigilance matters more than any dashboard color. He also describes how patterns like output beating outcome, performance theater, and risk box ticking show up in real projects and why they are so harmful when left unchallenged.

Tune into the next episode of Talk Law Radio Show and Podcast, where property management expert, Lorena N. Jáuregui de Birdy, dives deep into the must-know strategies for navigating residential rentals—like dodging common pitfalls, mastering tenant laws, and maximizing your investment returns. ⚖️

After another plague of delays, we finally complete our miniseries on aging with the darkest and most brutal depiction of it we've seen. Once again, we return to Natasha, Pierre, & The Great Comet of 1812 by Dave Malloy with "The Private and Intimate Life of the House." This isn't a fun one, so listen with care.   We will be back on January 15, 2026 with something unlike we've ever done -- stay tuned!   All clips are from 2017's Natasha, Pierre, and The Great Comet of 1812: Original Broadway Cast Recording featuring Gelsey Bell and Nicholas Belton and are protected by the Fair Use guidelines of Section 107 of the Copyright Act for criticism and commentary. All rights reserved to the copyright owners.   N.B. This episode was also plagued by some audio issues. It is entirely listenable, but it's a bit quiet at times. Management regrets the inconvenience. Listen to the SMSTS playlist on Spotify! Follow SMSTS on Instagram: @somuchstufftosing Email the show: somuchstufftosing@gmail.co  

Prosthetic joint infections (PJI) remain among the most devastating complications in orthopedic surgery, with increasing incidence paralleling the growth in arthroplasty procedures worldwide. While treatment protocols are well-established, evidence supporting current approaches is lacking, and outcomes remain suboptimal, highlighting the need for improved therapeutic strategies. AAC recently published a minireview of randomized controlled trials and emerging evidence for the management for these difficult to treat infection. Today, we discuss with one of the authors of the manuscript and an ID doctor specialized in PJI infections the findings of such paper. Topics discussed: Challenges of treating prosthetic joint infections. Major clinical trial data supporting different approaches for treatment and prevention of PJI Guidance for the approach to these complicated infections. Guests: David Paterson MBBS, Ph.D., Professor, Saw Swee Hock School of Public Health (Joint) Yong Loo Lin School of Public Health (Joint), Director, ADVANCE-ID, National University of Singapore, Singapore.  Ana Victoria Salas-Vargas, M.D. Assistant Professor of Clinical Medicine, Houston Methodist Academic Institute and Weill Cornell Medical College.  This episode is brought to you by the Antimicrobial Agents and Chemotherapy Journal.  Visit asm.org/aac to browse issues and/or submit a manuscript. If you plan to publish in AAC, ASM Members get up to 50% off publishing fees. Visit asm.org/joinasm to sign up.

In this episode, the CardioNerds (Dr. Naima Maqsood, Dr. Akiva Rosenzveig, and Dr. Colin Blumenthal) are joined by renowned educator in electrophysiology, Dr. Joshua Cooper, to discuss everything atrial flutter; from anatomy and pathophysiology to diagnosis and management. Dr. Cooper's expert teaching comes through as Dr. Cooper vividly describes atrial anatomy to provide the foundational understanding to be able to understand why management of atrial flutter is unique from atrial fibrillation despite their every intertwined relationship. A foundational episode for learners to understand atrial flutter as well as numerous concepts in electrophysiology. Audio editing for this episode was performed by CardioNerds intern Dr. Bhavya Shah.  CardioNerds Atrial Fibrillation PageCardioNerds Episode PageCardioNerds AcademyCardionerds Healy Honor Roll CardioNerds Journal ClubSubscribe to The Heartbeat Newsletter!Check out CardioNerds SWAG!Become a CardioNerds Patron! Pearls "The biggest mistake is failure to diagnose”. Atrial flutter, especially with 2:1 conduction, is commonly missed in both inpatient and outpatient settings so look carefully at that 12-lead EKG so you can mitigate the stroke and tachycardia induced cardiomyopathy risk  Decremental conduction of the AV node makes it more challenging to rate control atrial flutter than atrial fibrillation  Catheter Ablation is the first line treatment for atrial flutter and is highly successful, but cardioversion can be utilized as well prior to pursuing ablation in some cases.  Class I AADs like propafenone and flecainide may stability the atrial flutter circuit by slowing conduction and thus may worsen the arrhythmia. Therefore, the preferred anti-arrhythmic medication in atrial flutter are class III agents.  Atrial flutter can be triggered by firing from the left side of the heart, so in patients with both atrial fibrillation and flutter, ablating atrial fibrillation makes atrial flutter less likely to recur.  BONUS PEARL: Dr. Cooper's youtube video on atrial flutter is a MUST SEE!  Notes Notes: Notes drafted by Dr. Akiva Rosenzveig  What are the distinguishing features of atrial fibrillation and flutter?  Atrial flutter is an organized rhythm characterized by a wavefront that continuously travels around the same circuit leading to reproducible P-waves on surface EKG as well as a very mathematical and predictable relationship between atrial and ventricular activity  Atrial fibrillation is an ever changing, chaotic rhythm that consists of small local circuits that interplay off each other. Consequently, no two beats are the same and the relationship between the atrial activity and ventricular activity is unpredictable leading to an irregularly irregular rhythm  What are common atrial flutter circuits?  Cavo-tricuspid isthmus (CTI)-dependent atrial flutter is the most common type of flutter. It is characterized by a circuit that circumnavigates the tricuspid valve.  Typical atrial flutter is characterized by the circuit running in a counterclockwise pattern up the septum, from medial to lateral across the right atrial roof, down the lateral wall, and back towards the septum across the floor of the right atrium between the IVC and the inferior margin of the tricuspid valve i.e. the cavo-tricuspid isthmus. Surface EKG will show a gradual downslope in leads II, III, and AvF and a rapid rise at end of each flutter wave.   Atypical CTI-dependent flutter follows the same route but in the opposite direction (clockwise). Therefore, we will see positive flutter waves in the inferior leads   Mitral annular flutter is more commonly seen in atrial fibrillation patients who've been treated with ablation leading to scarring in the left atrium.  Roof-dependent flutter is characterized by a circuit that travels around left atrium circumnavigating a lesion (often from prior ablation), traveling through the left atrial roof, down the posterior wall, and around the pulmonary veins  Surgical/scar/incisional flutter is seen in people with a history of prior cardiac surgery and have iatrogenic scars in right atrium due to cannulation sites or incisions  How does atrial flutter pharmacologic management differ from other atrial arrhythmias?  The atrioventricular (AV) node is unique in that the faster it is stimulated, the longer the refractory period and the slower it conducts. This characteristic is called decremental conduction. In atrial fibrillation, the atrial rate is so fast that the AV node becomes overwhelmed and only lets some of those signals through to the ventricles creating an irregular tachycardia but at lower rates. In atrial flutter, the atrial rate is slower, therefore the AV node has more capability to conduct allowing for higher ventricular rates. Therefore, to achieve rate control one will need a higher dose of AV blocking medications. Atrial tachycardia may require even higher doses due to the increased ability of the AV node to conduct, as the atrial rates are slower than in atrial flutter.  Sodium channel blockers (Class I) such as flecainide and propafenone slow wavefront propagation, making it easier for the AV node to handle the atrial rates. This will end up leading to increased ventricular rates which can be dangerously fast. That is why AV nodal blockers should be used in conjunction with flecainide and propafenone.  What is the role of cardioversion in atrial flutter management?  Due to high success rate with atrial flutter ablation, ablation is the first line treatment. However, sometimes cardioversion may be utilized in patients depending on how symptomatic they are and how long it will take to get an ablation. Cardioversion may also be utilized preferentially when the atrial flutter was triggered by infection or cardiac surgery to see if it will come back.   If cardioversion is pursued, the patient will need to be anticoagulated due to the stroke risk after the procedure due to post-conversion stunning.  How effective is atrial flutter ablation?  The landmark Natale et al study in 2000 demonstrated 80% success rate after radiofrequency ablation as compared to 36% in patients on anti-arrhythmic therapy. The LADIP study in 2006 further corroborated these findings. Contemporary data shows above 90% success rate of atrial flutter ablation.  In patients who have had both atrial fibrillation and atrial flutter, most electrophysiologists would ablate both. However, in patients with atrial fibrillation, the atrial flutter usually is initiated by trigger spots firing in the left atrium. Once the atrial fibrillation is ablated, the flutter will become less likely. Therefore, there are those who say there's no need to ablate the flutter circuit as well. Alternatively, if a patient has severe comorbidities and/or is high risk for ablation, one may consider performing the atrial flutter ablation only since atrial flutter is harder to manage medically compared with atrial fibrillation.   How do you manage atrial flutter in the acute inpatient setting?  In the inpatient setting, electrical cardioversion is often limited by blood pressure and the hypotensive effects of the sedatives required. If one is awake and too hypotensive, chemical cardioversion can be pursued. The most effective anti-arrhythmic for this is ibutilide. Amiodarone is not effective for acute cardioversion. Since ibutilide prolongs refractoriness in atrial and ventricular tissue, there's a risk of long QT induced torsades de pointes. Pretreating with magneisum reduces the risk to 1-2%.  References Jolly WA, Ritchie WT. Auricular flutter and fibrillation. 1911. Ann Noninvasive Electrocardiol. 2003;8(1):92-96. doi:10.1046/j.1542-474x.2003.08114.x  McMichael J. History of atrial fibrillation 1628-1819 Harvey - de Senac - Laënnec. Br Heart J. 1982;48(3):193-197. doi:10.1136/hrt.48.3.193  Lee KW, Yang Y, Scheinman MM; University of Califoirnia-San Francisco, San Francisco, CA, USA. Atrial flutter: a review of its history, mechanisms, clinical features, and current therapy. Curr Probl Cardiol. 2005;30(3):121-167. doi:10.1016/j.cpcardiol.200  2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2024;149(1):e167. doi:10.1161/  Cosío F. G. (2017). Atrial Flutter, Typical and Atypical: A Review. Arrhythmia & electrophysiology review, 6(2), 55–62. https://doi.org/10.15420/aer.2017.5.2  https://www.escardio.org/Journals/E-Journal-of-Cardiology-Practice/Volume-11/Atrial-flutter-common-and-main-atypical-forms Natale A, Newby KH, Pisanó E, et al. Prospective randomized comparison of antiarrhythmic therapy versus first-line radiofrequency ablation in patients with atrial flutter. J Am Coll Cardiol. 2000;35(7):1898-1904. doi:10.1016/s0735-1097(00)00635-5  Da Costa A, Thévenin J, Roche F, et al. Results from the Loire-Ardèche-Drôme-Isère-Puy-de-Dôme (LADIP) trial on atrial flutter, a multicentric prospective randomized study comparing amiodarone and radiofrequency ablation after the first episode of symptomatic atrial flutter. Circulation. 2006;114(16):1676-1681. doi:10.1161/CIRCULATIONAHA.106.638395  https://www.acc.org/Membership/Sections-and-Councils/Fellows-in-Training-Section/Section-Updates/2015/12/15/16/58/Atrial-Fibrillation#:~:text=The%20first%20'modern%20day'%20account,in%20open%20chest%20animal%20models.&text=In%201775%2C%20William%20Withering%20first,(purple%20foxglove)%20in%20AFib.

Clonal mast cell disease is often missed because symptoms vary from person to person, tryptase levels can be normal, and bone marrow biopsies are hard to get. For some people, unexplained or very severe anaphylaxis may be an early sign of a clonal mast cell disease. In this episode, we review “Prevalence of KIT D816V in anaphylaxis or systemic mast cell activation,” published in October 2025 in the Journal of Allergy and Clinical Immunology. This paper, known as the PROSPECTOR trial, is looking at how often the KIT D816V mutation can be found using a blood test in adults who have had anaphylaxis or systemic mast cell activation symptoms. We break down why KIT D816V matters, how it connects to systemic mastocytosis, why HaT needs to be considered, and how newer blood tests may help doctors catch clonal mast cell disease earlier. What we cover in our episode about KIT D816V and anaphylaxis: Setting the stage: Understanding mast cell activation and anaphylaxis. Why KIT D816V matters: How this mutation fits into clonal mast cell disease, what blood testing can reveal, and when doctors still turn to a bone marrow biopsy. Making sense of tryptase and hereditary alpha-tryptasemia (HaT): Why baseline tryptase, the “20% + 2” rule, and HaT can make screening more complicated than it seems. What the PROSPECTOR trial uncovered: How often KIT D816V appeared in people with anaphylaxis, and other results on tryptase and HaT. How this helps patients: What these findings mean for anyone with unexplained or severe anaphylaxis, and how doctors combine KIT testing, tryptase, HaT, and symptoms to decide on next steps. Other podcast episodes about mast cell disease: Ep. 127: Management of indolent mastocytosis - A clinical yardstick Ep. 126: Management of mast cell activation syndrome - A clinical yardstick Ep. 121: Avapritinib vs Placebo in Indolent Systemic Mastocytosis - PIONEER Trial Ep. 118: The ISM Disconnect - Do Patients and Providers Agree on Symptom Control? Ep. 70 How do stress and low histamine diets impact mast cell disease? Ep. 63: Mast Cell Diseases & Systemic Mastocytosis: The Basic Science Ep. 65: The Symptoms and Triggers of Mast Cell Disease *********** The Itch Review, hosted by Dr. Gupta, Kortney, and Dr. Blaiss, explores allergy and immunology studies, breaking down complex research in conversations accessible to clinicians, patients, and caregivers. Each episode provides key insights from journal articles and includes a one-page infographic in the show notes for easy reference. *********** Made in partnership with The Allergy & Asthma Network. Thanks to Blueprint Medicines for sponsoring today's episode.  This podcast is for informational purposes only and does not substitute professional medical advice. Always consult with your healthcare provider for any medical concerns.

Why is it so expensive to build a house in America? That's a question economists, politicians and pundits have argued at length about, but can't agree on. In today's episode of Second Request, executive editor Teddy Downey sits down with Steven Xiao, Associate Professor of Finance at the University of Texas at Dallas Naveen Jindal School of Management and Ph.D candidate Zheng Liu for a robust discussion about how concentration in the homebuilding sector has led to increased costs and prices. To learn more about The Capitol Forum click here.

Interview with Chief Executive Officer, Keith BoyleOur previous interview: https://www.cruxinvestor.com/posts/new-found-gold-tsxvnfg-explorer-to-producer-8484Recording date: 3rd December 2025New Found Gold Corporation is executing a capital-efficient development strategy that combines near-term cash flow from the recently acquired Hammerdown mine with advancement of the flagship Queensway Gold Project in Newfoundland, Canada. The November 2025 Maritime Resources acquisition delivered two critical assets: a producing underground mine that poured first gold one day before closing, and the fully permitted Pine Cove mill that eliminates major infrastructure requirements for Queensway's planned 700-ton-per-day operation. Management's appointment of Cutfield Freeman to structure project financing for Queensway's $155 million initial capital requirement signals progress toward a debt-heavy capital structure, with Hammerdown cash flow serving as the equity portion to minimize shareholder dilution. Recent grade control drilling at five-meter spacing confirms exceptional grades at the Keats zone, with only 20% of results released from the 70,000-meter 2025 program. These dense drill patterns reduce estimation uncertainty in nuggety gold deposits and support anticipated resource upgrades in the 2026 technical report. Discovery of high-grade mineralization at Dropkick, located 11 kilometers from existing resources, demonstrates district-scale exploration potential beyond current mine plans. The company targets Q1 2026 permit submission for Queensway with approval expected in H2 2026, enabling development commencement toward late 2027 commercial production. Hammerdown is ramping to steady-state operations during H1 2026, providing cash generation that de-risks Queensway financing while maintaining exploration programs across both properties that could extend mine life and improve project economics.—Learn more: https://cruxinvestor.com/companies/new-found-goldSign up for Crux Investor: https://cruxinvestor.com

Interview with Pascal Hamelin, President & CEO of Abcourt Mines Inc.Our previous interview: https://www.cruxinvestor.com/posts/abcourt-mines-tsxvabi-new-quebec-producer-positioned-for-growth-cash-flow-buybacks-8051Recording date: 3rd December 2025Abcourt Mines (TSXV:ABI) has successfully transitioned from exploration to production at its Sleeping Giant mine in Quebec, representing an increasingly rare case study in debt-financed mine development that avoids the severe shareholder dilution typical of traditional equity-financed builds. The company secured $12 million in financing from Nebari—including C$8 million initial tranche, $2 million follow-on, and $2 million used to buy down the Triple Flag NSR royalty from 2% to 1.5%—and commenced gold production.October 2025 production reached 475 ounces whilst operating at conservative staffing levels and building mill circuit inventory. Management projects cash flow positivity by Q2 2026 at approximately 700 ounces monthly production, with current monthly burn rate below $1 million. The Nebari credit facility includes a two-year interest-only period until July 2027, providing critical runway to demonstrate operational consistency and build cash reserves before principal repayments commence.The operational leverage inherent in Abcourt's asset base is substantial. The company operates an 800-tonne-per-day mill (permitted for 950 tonnes per day) currently running at less than 45% capacity. Management targets 350 tonnes per day by autumn 2025, with the mill processing all current mine production in approximately eight hours on day shift only. Plans include expanding to two shifts in early 2026 and eventually four shifts as production scales, providing a clear pathway to meaningful production growth without major capital investment.The constraint on production growth is labour availability rather than geological or metallurgical factors. CEO Pascal Hamelin explicitly stated: "It's not the feed, it's the people, that's the problem you're trying to solve for." The company has invested in infrastructure to address recruitment challenges, including a sleep camp commissioned in September 2024 with Phase Two expansion pending permit approval.The current mine plan supports seven years producing 25,000–33,000 ounces annually, with variation driven by grade. Management's strategic priority centres on extending mine life to 10+ years through three underground drill rigs at Sleeping Giant, then increasing mining fronts to utilise full mill capacity. This narrow-vein, high-grade mining approach—room-and-pillar methods targeting veins 30 centimetres to one metre wide—inherently limits tonnes but maximises grade, with underground samples showing visible gold exceeding 300 g/t.The Flordin discovery adds significant exploration upside. Systematic work exposed 300 metres of strike length grading 5 g/t gold over 15–20 metres width at surface, located 138 kilometres from existing mill infrastructure within a potential two-kilometre mineralised corridor. Abcourt has planned 20,000 metres of drilling for 2026—winter programmes targeting the eastern extension towards Agnico Eagle's adjacent property boundary, spring/summer/autumn programmes targeting northwestern extensions—entirely funded from operating cash flow.Management and directors hold approximately 30% ownership, having consistently supported development through equity investments. Shareholders have expressed preference for share buybacks over dividends once balance sheet permits, with capital allocation decisions driven by financial strength rather than arbitrary timelines.Sustained gold prices above US$4,000 per ounce have fundamentally improved narrow-vein deposit economics. Every US$100 increase translates to approximately US$2.5–3.3 million in additional annual revenue at current production guidance. The investment case depends on execution during the 18-month ramp-up period, successful miner recruitment, and drilling success at both assets to extend mine life and confirm district-scale potential at Flordin.View Abcourt Mines' company profile: https://www.cruxinvestor.com/companies/abcourt-mines-incSign up for Crux Investor: https://cruxinvestor.com

Interview with Jon Deluce, Founder & CEO of Abitibi Metals Corp.Our previous interview: https://www.cruxinvestor.com/posts/abitibi-metals-cseamq-high-grade-copper-expansion-project-in-canada-7823Recording date: 4th December 2025Abitibi Metals Corp. (CSE:AMQ) is rapidly emerging as a compelling copper-gold story in Quebec's prolific mining belt, with CEO Jon Deluce outlining a disciplined growth strategy centered on the company's flagship B26 deposit. After drilling over 25,000 meters in 2025, the company is targeting a substantial resource update to 25-30 million tons in 2026, up from the current 2+ million ounce gold equivalent resource.The drilling program has delivered exceptional results, including intercepts of 18% copper equivalent over 6.3 meters with 6 grams per ton gold, and 4.5% copper equivalent over 21 meters. These world-class grades demonstrate the deposit's polymetallic nature and draw comparisons to the historic Selbaie mine located just 7 kilometers away, which produced 53 million tons over two decades.Strategic capital management has been central to Abitibi's approach. The company recently completed a bought deal financing through BMO at 35 cents per share—a 65% premium to the September market price—with no warrants attached. This structure attracted institutional investors and built the treasury to $23-24 million, funding 45,000 meters of drilling through 2027 while maintaining a clean capital structure.With a market capitalization of $65 million and an enterprise value of just $40 million, Deluce believes the company remains undervalued relative to its resource potential. The 2026 exploration strategy balances systematic resource expansion through 150-meter infill drilling with aggressive 600-meter step-outs designed to test whether B26 could reach tier-one scale comparable to Selbaie's 60-million-ton endowment.Management has assembled an experienced advisory board including Victor Cantore, Craig Parry, and Shane Williams, positioning the company for Quebec's active M&A environment. Rather than accepting dilutive 20% strategic investments, Abitibi is selectively pursuing a 5% partnership with a Quebec producer that would provide validation without eliminating competitive tension or capping shareholder upside as the copper market potentially enters a sustained bull phase.View Abitibi Metals' company profile: https://www.cruxinvestor.com/companies/abitibi-metalsSign up for Crux Investor: https://cruxinvestor.com

Private funders are increasingly shifting from funding short-term service delivery to long-term systems change, pushing nonprofits to rethink their role in their community. Many are now asking, how do we stay mission-focused while building the relationships needed to attract funders who want deeper change? In today's episode, we explore the idea of power ecosystems — what they are, how they work, and why they're reshaping the nonprofit-funder relationship. Tune in to learn how to identify your power ecosystem, build collective power, and engage private funders more effectively. Want to suggest a topic, guest, or nonprofit organization for an upcoming episode? Send an email with the subject "NPFX suggestion" to contact@ipmadvancement.com. Additional Resources Public Health and Racial Equity (PHaRE) Model for Systems Change https://gingerleeglobal.com/public-health-and-racial-equity-phare-model-for-systems-change/ [NPFX] Rethinking How We Do Good: What We Can Learn from This Funding Crisis https://www.ipmadvancement.com/npfx/rethinking-how-we-do-good-what-we-can-learn-from-this-funding-crisis [NPFX] Federal Funding Uncertainty: How to Assess the Risks and Respond Strategically https://www.ipmadvancement.com/npfx/federal-funding-uncertainty-how-to-assess-the-risks-and-respond-strategically [NPFX] Building Resilience in the Face of Funding Cuts https://www.ipmadvancement.com/npfx/building-resilience-in-the-face-of-funding-cuts [NPFX] Advocacy Matters: Defending Federal Funding for Nonprofits https://www.ipmadvancement.com/npfx/advocacy-matters-defending-federal-funding-for-nonprofits Guests Ginger Lee, DrPH, is the founder of the Ginger Lee Global Health Consulting Group, supporting communities and organizations committed to social justice and equitable systems change. Raised in low-resourced neighborhoods, she brings a deep commitment to community power building and transformational change. Dr. Lee has served as CEO of two nonprofits, a highly successful development director, a government policy maker, and president of a globally focused foundation. Her expertise centers on systems and organizational change, non-profit leadership, and on shifting traditional philanthropy to invest in systems-level solutions alongside direct service. She is the author of the research-based Public Health and Racial Equity (PHaRE) Model for Systems Change, which clarifies the mechanisms for systems transformation led by communities most impacted by inequities. https://www.linkedin.com/in/weavingchange/ https://gingerleeglobal.com/ Dr. Anthony "Tony" Iton, CEO of The Health Trust, is a physician, attorney, public health leader, and nationally recognized advocate for health equity. Over a career spanning more than 30 years, Dr. Iton has tackled systemic barriers to health and championed community-led solutions to address inequities. At The California Endowment, he served as Senior Vice President for Healthy Communities, leading the landmark $1 billion, 10-year Building Healthy Communities initiative—one of the largest philanthropic efforts of its kind in the nation. His visionary leadership focused on empowering marginalized communities, shifting policy systems, and reimagining public health practices. Dr. Iton holds an MD from Johns Hopkins University, a JD and MPH from UC Berkeley, and a BS in Neurophysiology from McGill University. He is a Lecturer of Health Policy and Management at UC Berkeley's School of Public Health and serves on the boards of national organizations focused on health equity, including the Public Health Institute and Prevention Institute. https://www.linkedin.com/in/drtonyiton/ https://healthtrust.org/ Elizabeth Silverstein has served the not-for-profit sector for more than 40 years, specializing in transformational giving, vision casting, inspiring boards, and building passionate, effective teams. Beth has been instrumental in cultivating major gifts for capital campaigns in healthcare, two presidential libraries, higher education, K-12 independent schools, and social service organizations. With an ardent passion for protecting and propelling the nonprofit sector, Beth has joined the team at VisionConnect, a consultancy specializing in strategic planning, coalition building, governance excellence, and nonprofit capacity building. A BoardSource-certified Governance Consultant, she is passionate about coaching boards toward purpose-driven leadership and crafting bold strategic plans that drive maximum mission impact. https://www.linkedin.com/in/elizabeth-reynolds-silverstein-b211b7a/ https://www.visionconnectllc.com/ Hosts Russ Phaneuf, a co-founder of IPM Advancement, has a background in higher education development, with positions at the University of Hartford, Northern Arizona University, and Thunderbird School of Global Management. As IPM's managing director & chief strategist, Russ serves as lead fundraising strategist, award-winning content creator, and program analyst specializing in applied system dynamics. https://www.linkedin.com/in/russphaneuf/ https://www.ipmadvancement.com/ Rich Frazier has worked in the nonprofit sector for over 35 years. In his roles as senior consultant with IPM Advancement and founder of VisionConnect LLC, Rich offers extensive understanding and knowledge in capital campaigns, fund development, strategic planning, and board of directors development. https://www.linkedin.com/in/richfrazier/ https://www.visionconnectllc.com/

In less than a decade, OnlyFans says it has grown into a business earning $7 billion a year. The digital platform is known for letting its 4 million creators share exclusive – often NSFW – content with more than 400 million paying users. So far, creators have earned $25 billion using OnlyFans. CEO Keily Blair revealed what's next for the brand with host Jeff Berman live on stage at Web Summit in Lisbon. Subscribe to the Masters of Scale weekly newsletter: https://mastersofscale.com/subscribe See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Happy Thursday, Besties!! Our Morgie girl is sick today, so after a good long post-holiday catch up (with a side crime account that happened to Tay this morning) Taylar get's into the case of Patrice Endres. Patrice was 38 years old when she disappeared from her hair salon in Cumming, GA (Forsyth County) on April 15, 2004 without a trace. Over the years, several developments and discoveries would come to light, but what happened to Patrice that day remains a mystery. Thanks so much for spending your Thursdays with us, besties! We love you so much and will talk to you on Tuesday in the TBB for Taylar's spiral that we have hinted at for 4 weeks now!! TTYL Need to Call Susan (Angel Wings and Healing Things)? Text Ellen at 704-562-3476 to book!! Make sure to tell her we sent you for a Besties only Special discount!! If you have a Creepy Account of your own you would like to submit, you can go to our Reddit (CreepsandCrimes) or email it to us at CREEPSANDCRIMES.CA@GMAIL.COM Creeps and Crimes Merch: ⁠⁠https://creepsandcrimesmerch.com/⁠⁠ Join our OG Pick Me Cult (Patreon): ⁠⁠https://patreon.com/creepsandcrimes⁠⁠ SUBSCRIBE AND SUPPORT WHEREVER YOU GET YOUR PODCASTS: - Apple Podcast: ⁠⁠https://podcasts.apple.com/us/podcast/creeps-and-crimes/id1533194848⁠⁠ - Spotify: ⁠⁠https://open.spotify.com/show/0v2kntCCfdQOSeMNnGM2b6?si=bf5c137913dd4af7⁠⁠ - Youtube: ⁠⁠https://youtube.com/@creepsandcrimespodcast?si=e6Lwuw6qvsEPBHzG⁠⁠ Business Inquiries please contact Management: ⁠⁠maggie@MRHentertainment.com⁠⁠ FOLLOW US ON SOCIALS: Creeps and Crimes Podcast - Insta: ⁠⁠https://www.instagram.com/creepsandcrimespodcast/?hl=en⁠⁠ - Facebook: ⁠⁠https://www.facebook.com/creepsandcrimespodcast/⁠⁠ - TikTok: ⁠⁠https://www.tiktok.com/@creepsandcrimes⁠⁠ Taylar Jane (True Crime Host) - Insta: @Taylarj - TikTok (True Crime Channel): @TaylarJane98 - TikTok (Personal): @TaylarJane1 Morgan Harris (Paranormal & Conspiracy Host) - Insta: @morgg.m - Tiktok: @morgg.m Want More Info? Check out our Website: ⁠⁠www.creepsandcrimespodcast.com⁠⁠ Send Us Mail & Fan Art to our PO Box!!! CREEPS AND CRIMES PODCAST PO BOX 11523 KNOXVILLE, TENNESSEE 37939 Have a Creepy Account You'd like to share and be featured on the Podcast? Email it to: ⁠⁠CreepsAndCrimes.CA@gmail.com⁠⁠ Submit it through the Portal on our Website (Listed above) or Post in on our Reddit Thread with the tag "creepy account" Love our TBB episodes and want to get in on the Action or submit an AIMS? Head over to our Reddit Community: @creepsandcrimes Need to contact us or request sources? Email us at ⁠⁠creepsandcrimespodcast@gmail.com Learn more about your ad choices. Visit podcastchoices.com/adchoices

Sticking rigidly to your sales scripts, hiring and firing sales reps, and positioning yourself as a freelancer instead of the expert: these mistakes will cost you in 2026 if you don't address them now. 6-figure fractional sales manager, Jeff Pecaro, joins us once again to reveal his best sales insights and call us out on the mistakes we need to leave behind in 2025. Plus, we get into how he and other 6-7 figure businesses inside Dynamite Circle are scaling with just one human and multiple bots. LINKS How to work with Jeff (https://meetwingman.com/) Jeff's favorite microphone for sales calls (https://www.amazon.com/Shure-MV7X-Podcast-Microphone-Voice-Isolating/dp/B09BZZCGC8/) Get 2 months of Perspective AI FREE with promo code TMBA (https://getperspective.ai/tmba) Share your thoughts about the podcast (https://getperspective.ai/interview/tmba-feedback) [takes 2 minutes] Connect with 6-, 7- & 8-figure founders in Dynamite Circle (https://dynamitecircle.com/dcbkk) Hang out exclusively with 7+ figure founders (https://dynamitecircle.com/dc-black) 22 FREE business resources for location-independent entrepreneurs (https://tropicalmba.com/resources) CHAPTERS (00:00:13) Today's Guest: Jeff Pecaro (00:01:44) The Biggest Challenge Holding Back Your Sales (00:05:00) Start Positioning Yourself as the Expert (00:14:31) Conversion Rate Benchmarks to Aim For (00:18:59) How to Go From “Good Call” to $ in the Bank (00:26:33) Sales Best Practices in 2026 (00:32:24) 2026 Bootstrapper Trends and Predictions CONNECT: Dan@tropicalmba.com Ian@tropicalmba.com Past guests on TMBA include Cal Newport, David Heinemeier Hannson, Seth Godin, Ricardo Semler, Noah Kagan, Rob Walling, Jay Clouse, Einar Vollset, Sam Dogan, Gino Wickam, James Clear, Jodie Cook, Mark Webster, Steph Smith, Taylor Pearson, Justin Tan, Matt Gartland, Ayman Al-Abdullah, Lucy Bella. PLAYLIST: Your 2026 Business Plan in 36 Minutes (https://tropicalmba.com/episodes/2026-business-plan) [FREE Resource] $400K in Points & 100% Vibe Coded Shopify Forecasting App with “SpyGuy” Allen Walton (https://tropicalmba.com/episodes/400k-in-points-vibe-coded-app) The Lifestyle Business Playbook (2025 Edition) (https://tropicalmba.com/episodes/lifestyle-business-playbook-2025)

I was out drinking martinis with Cora Opsahl, director of 32BJ Health Fund, and Cora said, "Look, most plan sponsors' biggest expense is health system spend, hospital spend." I know this is an unexpected start to an episode about pharmaceutical pricing and value featuring Sarah Emond, CEO of ICER (Institute for Clinical and Economic Review). But yeah, 50% of most plan sponsors' spend these days goes to health systems. Fifty percent! One half! For a full transcript of this episode, click here. If you enjoy this podcast, be sure to subscribe to the free weekly newsletter to be a member of the Relentless Tribe. So, if a patient who is adherent to a drug and that drug keeps that patient out of the hospital, why do I want to make a patient have excessive skin in the game to get that drug, which everybody knows at this point this "skin in the game" can cause said patient to not be adherent in many cases, cost being a very big reason patients give for not taking medications as prescribed. So then we have this not adherent patient who winds up in the hospital, via the ER often enough. The core issue here that surfaced, bottom line—and I'm not sure if this was in spite of the martinis or as a result of them—but while hospital spend is the largest health expense, high-value drugs that prevent hospitalization often face patient cost sharing and access restrictions, which leads to poor patient adherence and ultimately higher system cost potentially. So then Cora and I spent the next half hour debating when the statement is empirically true and when it's not. And you know what it all boils down to? What's the value of the drug? Do we even know what that means to start? But if it's determined that the drug is relatively high value, then the plan desperately should want to do everything possible to keep that patient on that medication, and cost sharing is a huge barrier to adherence. Today, as I said, I'm speaking with Sarah Emond, CEO over at ICER, and we get into all of this in the conversation that follows. In fact, most of the conversation that follows explores the tensions that exist in the current way that we sell and buy pharmaceutical products. I'm just gonna sum up these tensions in a list here at the top of this show. There's six of them that Sarah Emond and I discussed today by my counting, and each of these we explore in some depth. So, here's the list. Tension 1: The value of any given drug (in other words, what is the fair price for that drug considering the health gains that it delivers) versus the total cost to the plan for the total population taking that drug. GLP-1s have entered the chat. GLP-1s (by ICER's analysis, at least) are super high-value drugs that also can bankrupt plans due to the number of folks who may benefit from taking the drug. Definitely a tense tension to kick off our list here. Tension 2: The list or net price of a drug versus patient access and affordability. Again, this can be tense in an area of much misalignment. You can have a great well-priced drug with huge patient affordability and access challenges because drug net price and coinsurance amounts often have nothing to do with each other. Tension 3: Lifetime value of a drug versus a 3-, 2.5-year, whatever time horizon that many plan sponsor actuaries use in their value assessment. We discussed this today, but there's a Summer Short (SUMS7) on actuarial value horizons with Keith Passwater and JR Clark if you wanna dig in on this further. Tension 4: The tension between the societal value of a drug or even the patient's perceived value of a drug versus what an employer plan sponsor might perceive as the value. What is the formula used to determine value? What's in and what's out? So, that's a bigger conversation just beyond the time horizon for what's included in this calculation. Tension 5: Exacerbating the what's included in the value contemplation beyond just what you include in there is the tension between what is hypothetically of value and what is possible to measure. If you have pharma datasets and medical datasets separate in silos, who knows how many hospital readmissions were prevented by whatever drug? And how much presenteeism or absenteeism exists. I mean, it is an outlier, again, if anyone even knows the net price they paid for a drug, just to level set context here. Tension 6: Lowering financial barriers for patients to take drugs that are of value versus status quo goals and incentives. Like, for example, PBMs (pharmacy benefit managers) are often told that their goal is to reduce drug spend. Okay … so, how do I do that? Oh, reduce access either by prior auths or delay tactics or really high coinsurance, which is gonna reduce adherence by design. And it's someone else's problem—if I'm just thinking like a status quo PBM—if medical spend goes up, right? So, that's our last and not insignificant tension. And look, who comes out the loser in all of these tensions when they get tense? Patients. Not pricing based on value and not buying and setting up cost sharing based on value punishes patients and also plan sponsors or any other ultimate purchaser in the long term, given that the plan is but a population of patients if you start thinking about it in that context. Here is Sarah's advice in a nutshell: Pharma, sell. Pick your price based on something other than market power. And some pharma companies are actually dipping their toe into these waters and doing it. But then PBMs and plan sponsors have to hold up their end of the bargain here and buy drugs based on their value, not just the size of their rebates or some other discounting promise. And then we gotta continue the through line through to member affordability and access. High-value drugs should get preferred. So, right, do a high-value formulary. Listen to the show with Nina Lathia, RPh, MSc, PhD (EP426) on high-value formularies and then listen (after you're done with that one) to episode 435 with Dan Mendelson entitled "Optimized Pharmacy Benefits Are Required if You Want to Do or Buy Value-Based Care." Also, as I said, GLP-1s come up in this conversation, so … yeah, buckle up. One last thing, besides my normal thank you to Aventria Health Group for sponsoring this episode, I am so pleased to thank Payerset for donating to help Relentless Health Value stay on the air. Payerset is a price transparency company with a mission to create fair and equitable healthcare for everyone. Love that. Payerset empowers healthcare organizations, employers, and patients with the most complete set of healthcare price transparency data. They benchmark every negotiated rate and claim and delivering the actionable insights needed for smarter contract negotiations and a more transparent healthcare system. As I have said several times today, my conversation is with Sarah Emond, CEO of ICER. Also mentioned in this episode are Institute for Clinical and Economic Review (ICER); Cora Opsahl; 32 BJ Health Fund; Keith Passwater; JR Clark; Nina Lathia, RPh, MSc, PhD; Dan Mendelson; Aventria Health Group; Payerset; Antonio Ciaccia; Elizabeth Mitchell; Purchaser Business Group on Health (PBGH); Shane Cerone; Sam Flanders, MD; Mark Cuban; Morgan Health; and Tom Nash. For a list of healthcare industry acronyms and terms that may be unfamiliar to you, click here. You can learn more at ICER.org and follow Sarah on LinkedIn.   Sarah K. Emond, MPP, is president and chief executive officer of the Institute for Clinical and Economic Review (ICER), a leading nonprofit health policy research organization, with 25 years of experience in the business and policy of healthcare. She joined ICER in 2009 as its first chief operating officer and third employee and has worked to grow the organization's approach, scope, and impact over the years. Prior to joining ICER, Sarah spent time as a communications consultant, with six years in the corporate communications and investor relations department at a commercial-stage biopharmaceutical company and several years with a healthcare communications firm. Sarah began her healthcare career in clinical research at Beth Israel Deaconess Medical Center in Boston. A graduate of the Heller School for Social Policy and Management at Brandeis University, Sarah holds a Master of Public Policy degree with a concentration in health policy. Sarah also received a bachelor's degree in biological sciences from Smith College. Sarah speaks frequently at national conferences on the topics of prescription drug pricing policy, comparative effectiveness research, and value-based healthcare.   08:18 Why list prices are a lie. 10:59 How does the rebate model sometimes get in the way of paying for value? 12:50 Bonus clip with Sarah Emond. 13:14 EP491 with Elizabeth Mitchell. 13:20 EP490 and EP492 with Shane Cerone and Sam Flanders, MD. 14:37 The tension that is created between affordability and adherence. 15:03 When cost sharing makes sense in pharmaceutical drug pricing. 17:26 INBW42 with Stacey on moral hazard. 18:53 How GLP-1s are "wildly cost effective." 21:32 Why the sticker shock on cost-effective drugs is a failure in the system for paying for value. 22:38 ICER's report on GLP-1s. 26:59 EP385 with Dan Mendelson. 28:57 How employers and payers can have a value assessment approach and a health insurance system that allows access to cost-effective drugs. 29:48 How cost-effective prices are calculated. 31:55 One of the core value underpinnings for value assessment of drugs. 34:54 Why manufacturers and pharmacy benefit managers should work together more by referencing something like an ICER report. 36:55 EP426 with Nina Lathia, RPh, MSc, PhD. 38:21 "We can make different choices."   You can learn more at ICER.org and follow Sarah on LinkedIn.   @sarahkemond discusses #pharmaceutical #drugpricing on our #healthcarepodcast. #healthcare #podcast #financialhealth #patientoutcomes #primarycare #digitalhealth #healthcareleadership #healthcaretransformation #healthcareinnovation   Recent past interviews: Click a guest's name for their latest RHV episode! Stacey Richter (INBW43), Olivia Ross (Take Two: EP240), John Quinn, Dr Sam Flanders and Shane Cerone (EP492), Elizabeth Mitchell (EP491), Shane Cerone and Dr Sam Flanders (Part 1), Dan Greenleaf (Part 2), Dan Greenleaf (Part 1), Mark Cuban and Cora Opsahl

Not gonna give much of an introduction here because this is a short bonus level set, but I did just wanna call everyone's attention to the "arms race" created by our status quo purchasing and selling of many things, pharmaceuticals included. For a full transcript of this episode, click here. If you enjoy this podcast, be sure to subscribe to the free weekly newsletter to be a member of the Relentless Tribe. For example, raise the list price of a drug to maximize rebates, because the higher the list, the bigger the discount you can give, which then exacerbates patient affordability because coinsurance is often based on list price. But then Pharma starts offering co-pay cards, which messes up the whole PBM (pharmacy benefit manager) plan to drive patients to their highest-rebate products (ie, the most profitable products). So then maximizers and accumulators enter the chat, and prior auths ramp up because plans start having to raise premiums after enough 340B drugs with high lists and no rebates, and then there's no cost containment and raise deductibles and around and around we go. Meanwhile, is this drug fundamentally worth the list price or even the net price? Is it an effective drug? What's the right price to be paying for this drug? Should be the operative question, right? Just like what's the quality and appropriateness of any medical service? Maybe we should just quit it and just pay for value. And with that, let me introduce Sarah Emond, CEO of ICER (Institute for Clinical and Economic Review), and I will let Sarah tell the rest of the story. Also mentioned in this episode are Institute for Clinical and Economic Review (ICER); Cora Opsahl; 32 BJ Health Fund; Payerset; Aventria Health Group; Dea Belazi, PharmD, MPH; and Tom Nash. For a list of healthcare industry acronyms and terms that may be unfamiliar to you, click here.   You can learn more at ICER.org and follow Sarah on LinkedIn.   Sarah K. Emond, MPP, is president and chief executive officer of the Institute for Clinical and Economic Review (ICER), a leading nonprofit health policy research organization, with 25 years of experience in the business and policy of healthcare. She joined ICER in 2009 as its first chief operating officer and third employee and has worked to grow the organization's approach, scope, and impact over the years. Prior to joining ICER, Sarah spent time as a communications consultant, with six years in the corporate communications and investor relations department at a commercial-stage biopharmaceutical company and several years with a healthcare communications firm. Sarah began her healthcare career in clinical research at Beth Israel Deaconess Medical Center in Boston. A graduate of the Heller School for Social Policy and Management at Brandeis University, Sarah holds a Master of Public Policy degree with a concentration in health policy. Sarah also received a bachelor's degree in biological sciences from Smith College. Sarah speaks frequently at national conferences on the topics of prescription drug pricing policy, comparative effectiveness research, and value-based healthcare.   02:28 What is ICER? 02:47 What does the Institute for Clinical and Economic Review do? 05:09 The importance of still showing up, even when others don't understand or disagree. 06:51 EP293 ("Game Theory Gone Wild") with Dea Belazi, PharmD, MPH. 09:04 Why it's important to think about population health and how our choices impact affordability for everyone.   You can learn more at ICER.org and follow Sarah on LinkedIn.   @sarahkemond discusses #ICER and the status quo of #pharmaceuticaldrug #pricing on our #healthcarepodcast. #healthcare #podcast #financialhealth #patientoutcomes #primarycare #digitalhealth #healthcareleadership #healthcaretransformation #healthcareinnovation   Recent past interviews: Click a guest's name for their latest RHV episode! Stacey Richter (INBW43), Olivia Ross (Take Two: EP240), John Quinn, Dr Sam Flanders and Shane Cerone (EP492), Elizabeth Mitchell (EP491), Shane Cerone and Dr Sam Flanders (Part 1), Dan Greenleaf (Part 2), Dan Greenleaf (Part 1), Mark Cuban and Cora Opsahl  

WELCOME TO THE VIBE! This week, Kelly Cardenas sits down with the visionary Founder & CEO of Lovesac, Shawn D. Nelson! (Nasdaq: LOVE).We're diving into the mindset of the man who started his journey by making Sacs by hand in college in 1998 and scaled it into the fastest-growing furniture brand in the US, now projected to exceed $1 Billion in annual sales. Get ready for a masterclass in entrepreneurship, sustainable design, and disruptive innovation!In this game-changing conversation, you'll learn about:The Branson Blueprint: The legendary story of how Shawn won a million-dollar investment from Sir Richard Branson on The Rebel Billionaire and served as acting President of Virgin Worldwide.Design Meets Strategy: How his Master's degree in Strategic Design and Management from the world-famous Parsons, The New School for Design shaped Lovesac's strategy.The Sactionals Secret: The innovation behind the Sactionals platform—the world's most versatile couch—and how Shawn holds over 50 issued patents.True Sustainability: An in-depth look at his unique "Designed For Life" philosophy, which demands products are built to last a lifetime and evolve, promoting genuine sustainability.Lessons for Leaders: Insights from his book, Let Me Save You 25 Years, detailing the colorful history, "mistakes, miracles, and lessons" learned while building a vibrant culture.Connect with Kelly Cardenas & The Vibe:Connect with Shawn D. Nelson:Visit or listen to his Let Me Save You 25 Years podcast to learn more.

Why do leaders jump so quickly to giving advice? And why does it so often backfire? In this episode, Michael Bungay Stanier explains why the “advice monster” is one of our biggest leadership liabilities—and how seven simple questions can help you listen better, coach smarter, and build stronger connections. Filled with humor, story, empathy, and practical scripts, this episode is a masterclass in everyday leadership.Memorable Quotes“When you ask a question and they actually have to think about it, you're literally creating new neural pathways in their brain—or at least they're creating their own neural pathways—so they're literally becoming smarter right in front of you.”“More deeply than an ‘answer,' much of the time people want to feel deeply heard, deeply seen, and deeply encouraged. And your ‘answer' often means they feel less seen, less heard, and less encouraged.”“One of the great moments of claiming adulthood is being clear on what you want to say ‘yes' to—and knowing that inevitably you have to say ‘no' to things to get that.”“Every time you jump in with your ideas and your opinions and your advice—particularly if it's your default reaction—you're basically reinforcing, ‘I'm better than you are. I'm smarter and wiser and older and faster and just generally better than you. You are not as good as I am.' There's a degree to which you're diminishing that other person rather than helping them.”“There's a time and a place where [giving advice] is the right thing to be doing. The way I define coaching is: Can you stay curious a little bit longer? Can you rush to action and advice-giving a little bit more slowly?”“One of the phrases I've started saying to people who are going through a tough time is simply, ‘I'm Team Michael. I'm Team Megan.…I'm Team whoever that person might be.' It's my way of saying, ‘I love you and I want the best for you, and I don't even know what to do—or I can't think of anything to do—so I'm just trying to be with you in this moment.'”“One of the questions that I've found most helpful—particularly if I'm the more senior person in the relationship—is: ‘What needs to be said that hasn't yet been said?'”Key TakeawaysThe “Advice Monster” Is Real. Our instinct to help by offering answers often diminishes others. Curiosity, not certainty, is what truly empowers people.Questions Create Ownership. When people generate their own ideas, they're more confident, more committed, and more capable.Seven Questions Change Everything. Michael's practical framework gives you a simple playbook for better conversations. His personal favorite? “And what else?”Curiosity Deepens Every Relationship. Parents, partners, bosses—everyone benefits when you resist the urge to fix and choose to listen instead.Better Conversations Start With Permission. Rather than assume what someone needs, lead with humility and ask: How can I be most useful here?Coaching Is for Everyday Life. You don't have to be a professional coach for this to matter. These tools transform team meetings, parenting moments, and even difficult conversations at home.ResourcesThe Coaching Habit by Michael Bungay StanierThe Advice Trap by Michael Bungay StanierHow to Work With (Almost) Anyone by Michael Bungay StanierBox of Crayons (Curiosity-driven leadership program)Watch on YouTube at:  https://youtu.be/WOjq8aMbr5kThis episode was produced by Sarah Vorhees Wendel of VW Sound

The State Of The Union of churches in 2025, bad Jesus interactions, Pastor load management, Going to online church, and pastors using AI… On the net, it's a positive. ----- JOKES FOR HUMANS TOUR: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://johncristcomedy.com/tour/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ 12/5 - Phoenix, AZ 12/6 - Santa Rosa, CA 12/7 - Redding, CA 12/11 - South Bend, IN 12/12 - Munhall, PA 12/14 - Buffalo, NY 1/23 - Joliet, IL 1/24 - Effingham, IL 1/25 - Nashville, TN 2/20 - Springfield, MO 2/22 - Louisville, KY 2/26 - Ithaca, NY 2/27 - Reading, PA 2/28 - Glenside, PA 3/1 - New York, NY 3/20 - Jackson, MI 3/21 - Rockford, IL 3/22 - Cedar Rapids, IA 3/27 - Columbia, MO 3/28 - Fayetteville, AR 3/29 - Little Rock, AR 4/10 - Stockton, CA 4/11 - Anaheim, CA 4/12 - Thousand Oaks, CA 4/17 - Tucson, AZ 4/18 - Houston, TX 5/2 - Fort Worth, TX 5/3 - Amarillo, TX 5/14 - Wilmington, NC 5/15 - Evans, GA 5/16 - Durham, NC 5/29 - Jacksonville, FL 5/30 - Asheville, NC 5/31 - Columbia, SC 6/4 - Mobile, AL 6/5 - Florence, AL 6/6 - Duluth, GA ----- Catch the full video podcast on ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠YouTube⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠, and follow us on social media (⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠@netpositivepodcast⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠) for clips, bonus content, and updates throughout the week. ----- Email us at netpositive@johncristcomedy.com ----- FOLLOW JOHN ON: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Instagram⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Twitter⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠TikTok⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Facebook⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠YouTube⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ----- SUPPORT OUR SPONSORS AG1: Get a FREE gift with your first order at https://DrinkAG1.com/netpositive to get started with AG1's Next Gen and and notice the benefits for yourself. BLUELAND: Get 30% off your order by going to https://blueland.com/netpositive MIRACLE MADE: Save OVER 40% + 3 free towels with promo code NETPOSITIVE at https://trymiracle.com/NETPOSITIVE ----- PRODUCED BY: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Alex Lagos⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ / ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Easton Smith⁠⁠⁠⁠ / ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Lagos Creative⁠ Learn more about your ad choices. Visit megaphone.fm/adchoices

It's Ticked Off Tuesday, and Jared is hearing 4 new complaints! First, we hear about his condo management miscommunications. Then we go into listener emails. A listener sold an air purifier to a friend's mom and now is somehow stuck mailing a random remote to a stranger? Then, someone is frustrated with UberEats tipping because it keeps messing up their orders. Next, a cat owner is annoyed that friends keep giving cheap toys that break and leave glitter everywhere. And finally, a listener who loves hosting is tired of Thanksgiving food being boring and wants it to taste better.Eat smart @ http://factormeals.com/jtrain50off & use code jtrain50off to get 50% off your first box, plus Free Breakfast for 1 year.

A recent New York Times headline — “Did Women Ruin the Workplace?” sparked a firestorm across social media. Bob Safian welcomes a leader pushing back on this notion with data and nuance: Alison Moore, CEO of Chief, the prestigious network for senior women executives. Drawing from an exclusive nationwide survey of women leaders, Moore unpacks how evolving career paths are being misread, why women-centered spaces remain vital, and the rise of the multihyphenate leader. As a former HBO executive, Moore also reveals how she's applying lessons from Game of Thrones to Chief, and how she stays attuned to the cultural pulse, from AI to shifting leadership expectations.Visit the Rapid Response website here: https://www.rapidresponseshow.com/See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.